Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ASPRV1 (Aspartic peptidase retroviral like 1) is a protein-coding gene that encodes a retroviral-like protease involved in the processing of profilaggrin to filaggrin, which is essential for skin barrier formation and maintenance. Its expression is localized mainly in the epidermis and hair follicles, and loss-of-function variants are implicated in congenital ichthyosis and other skin barrier disorders. It functions as an aspartic-type endopeptidase and is not known to be directly targeted by approved pharmaceuticals.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Aspartic peptidase retroviral like 1 (ASPRV1).